TongXinLuo
- Generic Name
- TongXinLuo
Tongxinluo Capsule for Coronary Microvascular Disease
Phase 4
Not yet recruiting
- Conditions
- Coronary Microvascular Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-01-07
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT04220372
China Tongxinluo Study for Myocardial Protection in Patients With Acute Myocardial Infarction
- First Posted Date
- 2019-01-03
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- China National Center for Cardiovascular Diseases
- Target Recruit Count
- 3796
- Registration Number
- NCT03792035
- Locations
- 🇨🇳
Fuwai Hospital, Beijing, Beijing, China
🇨🇳Beijing Aerospace General Hospital, Beijing, Beijing, China
🇨🇳Beijing Renhe Hospital, Beijing, Beijing, China
Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease
- First Posted Date
- 2012-11-04
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Han Yaling
- Target Recruit Count
- 134
- Registration Number
- NCT01721590
- Locations
- 🇨🇳
ShenZhou Hopital Of ShenYang Medical College, ShengYang, Liaoning, China
🇨🇳Northern Hospital, Shenyang, Liaoning, China
🇨🇳The 463th Hospital Of PLA, ShenYang, Liaoning, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath